Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study.

Lassen, Mats C Højbjerg; Skaarup, Kristoffer Grundtvig; Vaduganathan, Muthiah; Ostrominski, John W; Jensen, Jens Ulrik Stæhr; Biering-Sørensen, Tor; Johansen, Niklas Dyrby.

Afiliação

Lassen MCH; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej 1, 2900 Copenhagen, Denmark.
Skaarup KG; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark.
Vaduganathan M; Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ostrominski JW; Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej 1, 2900 Copenhagen, Denmark.
Jensen JUS; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark.
Biering-Sørensen T; Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Johansen ND; Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Eur J Prev Cardiol ; 2024 Jul 18.

Article em En | MEDLINE | ID: mdl-39021164

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article